<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8186461" created="27/10/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8186461</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="calcineurin" sem="Protein_molecule">Calcineurin</term> potentiates activation of the <term id="T2" lex="granulocyte-macrophage_colony-stimulating_factor_gene" sem="DNA_domain_or_region">granulocyte-macrophage colony-stimulating factor gene</term> in <term id="T3" lex="T_cell" sem="Cell_natural">T cells</term>: involvement of the <term id="T4" lex="conserved_lymphokine_element_0" sem="DNA_domain_or_region">conserved lymphokine element 0</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="T2"/>
<clue>Calcineurin potentiates <clueType>activation</clueType> <linkTheme>of</linkTheme> the granulocyte-macrophage colony-stimulating factor gene in T cells: involvement of the conserved lymphokine element 0.</clue>
</event>
<event id="E2">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="T1"/>
<clue>Calcineurin <clueType>potentiates</clueType> activation of the granulocyte-macrophage colony-stimulating factor gene <clueLoc>in T cells</clueLoc>: involvement of the conserved lymphokine element 0.</clue>
</event>
<event KT="Investigation" id="E3">
<type class="Correlation"/>
<theme idref="E2"/>
<theme idref="T4"/>
<clue>Calcineurin potentiates activation of the granulocyte-macrophage colony-stimulating factor gene in T cells: <clueType>involvement</clueType> <linkCause>of</linkCause> the conserved lymphokine element 0.</clue>
<comment>NO COREFTHEME FOR E2</comment></event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T5" lex="granulocyte-macrophage_colony-stimulating_factor" sem="Protein_molecule">Granulocyte-macrophage colony-stimulating factor</term> (<term id="T6" lex="GM-CSF" sem="Protein_molecule">GM-CSF</term>) and <term id="T7" lex="interleukin-2" sem="Protein_molecule">interleukin-2</term> (<term id="T8" lex="IL-2" sem="Protein_molecule">IL-2</term>) are produced by stimulation with <term id="T9" lex="phorbol-12-myristate_acetate" sem="Organic_compound_other">phorbol-12-myristate acetate</term> (<term id="T10" lex="PMA" sem="Organic_compound_other">PMA</term>) and <term id="T11" lex="calcium_ionophore" sem="Organic_compound_other"><term id="T12" lex="calcium" sem="Element">calcium</term> ionophore</term> (<term id="A1" sem="Organic_compound_other">A23187</term>) in <term id="T13" lex="human_T_cell_leukemia_Jurkat_cell" sem="Cell_cultured">human T cell leukemia <term id="T14" lex="Jurkat_cell" sem="Cell_cultured">Jurkat cells</term></term>.</sentence>
<event KT="Other" id="E4">
<type class="Gene_expression"/>
<theme idref="T6"/>
<clue>Granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-2 (IL-2) are <clueType>produced</clueType> by stimulation with phorbol-12-myristate acetate (PMA) and calcium ionophore (A23187) in human T cell leukemia Jurkat cells.</clue>
</event>
<event KT="Other" id="E5">
<type class="Gene_expression"/>
<theme idref="T8"/>
<clue>Granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-2 (IL-2) are <clueType>produced</clueType> by stimulation with phorbol-12-myristate acetate (PMA) and calcium ionophore (A23187) in human T cell leukemia Jurkat cells.</clue>
</event>
<event KT="Fact" id="E8">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="T10"/>
<clue>Granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-2 (IL-2) are produced <linkCause>by stimulation with</linkCause> phorbol-12-myristate acetate (PMA) and calcium ionophore (A23187) <clueLoc>in human T cell leukemia Jurkat cells</clueLoc>.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Fact" id="E9">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="T10"/>
<clue>Granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-2 (IL-2) are produced <linkCause>by stimulation with</linkCause> phorbol-12-myristate acetate (PMA) and calcium ionophore (A23187) <clueLoc>in human T cell leukemia Jurkat cells</clueLoc>.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Fact" id="E10">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="A1"/>
<clue>Granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-2 (IL-2) are produced <linkCause>by stimulation with</linkCause> phorbol-12-myristate acetate (PMA) and calcium ionophore (A23187) <clueLoc>in human T cell leukemia Jurkat cells</clueLoc>.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Fact" id="E11">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="A1"/>
<clue>Granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-2 (IL-2) are produced <linkCause>by stimulation with</linkCause> phorbol-12-myristate acetate (PMA) and calcium ionophore (A23187) <clueLoc>in human T cell leukemia Jurkat cells</clueLoc>.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S3">The expression of <term id="T15" lex="GM-CSF" sem="Protein_molecule">GM-CSF</term> and <term id="T16" lex="IL-2" sem="Protein_molecule">IL-2</term> is inhibited by <term id="T17" lex="immunosuppressive_drug" sem="Organic_compound_other">immunosuppressive drugs</term> such as <term id="T18" lex="cyclosporin_A" sem="Organic_compound_other">cyclosporin A</term> (<term id="T19" lex="CsA" sem="Organic_compound_other">CsA</term>) and <term id="T20" lex="FK506" sem="Organic_compound_other">FK506</term>.</sentence>
<event KT="Other" id="E12">
<type class="Gene_expression"/>
<theme idref="T15"/>
<clue>The <clueType>expression</clueType> <linkTheme>of</linkTheme> GM-CSF and IL-2 is inhibited by immunosuppressive drugs such as cyclosporin A (CsA) and FK506.</clue>
</event>
<event KT="Other" id="E13">
<type class="Gene_expression"/>
<theme idref="T16"/>
<clue>The <clueType>expression</clueType> <linkTheme>of</linkTheme> GM-CSF and IL-2 is inhibited by immunosuppressive drugs such as cyclosporin A (CsA) and FK506.</clue>
</event>
<event KT="Fact" id="E14">
<type class="Negative_regulation"/>
<theme idref="E12"/>
<cause idref="T17"/>
<clue>The expression of GM-CSF and IL-2 is <clueType>inhibited</clueType> <linkCause>by</linkCause> immunosuppressive drugs such as cyclosporin A (CsA) and FK506.</clue>
</event>
<event KT="Fact" id="E15">
<type class="Negative_regulation"/>
<theme idref="E12"/>
<cause idref="T19"/>
<clue>The expression of GM-CSF and IL-2 is <clueType>inhibited</clueType> <linkCause>by</linkCause> <corefCause>immunosuppressive drugs</corefCause> such as cyclosporin A (CsA) and FK506.</clue>
</event>
<event KT="Fact" id="E16">
<type class="Negative_regulation"/>
<theme idref="E12"/>
<cause idref="T20"/>
<clue>The expression of GM-CSF and IL-2 is <clueType>inhibited</clueType> <linkCause>by</linkCause> <corefCause>immunosuppressive drugs</corefCause> such as cyclosporin A (CsA) and FK506.</clue>
</event>
<event KT="Fact" id="E17">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<cause idref="T17"/>
<clue>The expression of GM-CSF and IL-2 is <clueType>inhibited</clueType> <linkCause>by</linkCause> immunosuppressive drugs such as cyclosporin A (CsA) and FK506.</clue>
</event>
<event KT="Fact" id="E18">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<cause idref="T19"/>
<clue>The expression of GM-CSF and IL-2 is <clueType>inhibited</clueType> <linkCause>by</linkCause> <corefCause>immunosuppressive drugs</corefCause> such as cyclosporin A (CsA) and FK506.</clue>
</event>
<event KT="Fact" id="E19">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<cause idref="T20"/>
<clue>The expression of GM-CSF and IL-2 is <clueType>inhibited</clueType> <linkCause>by</linkCause> <corefCause>immunosuppressive drugs</corefCause> such as cyclosporin A (CsA) and FK506.</clue>
</event>
<sentence id="S4">Earlier studies on the <term id="T21" lex="IL-2_gene_expression" sem="Other"><term id="T22" lex="IL-2" sem="DNA_domain_or_region">IL-2 gene</term> expression</term> showed that overexpression of <term id="T23" lex="calcineurin" sem="Protein_molecule">calcineurin</term> (<term id="T24" lex="CN" sem="Protein_molecule">CN</term>), a <term id="T25" lex="Ca2+/calmodulin-dependent_protein_phosphatase" sem="Protein_family_or_group">Ca2+/calmodulin-dependent protein phosphatase</term>, can stimulate <term id="T26" lex="transcription" sem="Other">transcription</term> from the <term id="T27" lex="IL-2_promoter" sem="DNA_domain_or_region"><term id="T28" lex="IL-2" sem="Protein_molecule">IL-2</term> promoter</term> through the <term id="T29" lex="NF-AT-binding_site" sem="DNA_domain_or_region">NF-AT-binding site</term>.</sentence>
<event KT="Investigation" Source="Other" id="E20">
<type class="Gene_expression"/>
<theme idref="T22"/>
<clue><clueSource>Earlier <clueKT>studies</clueKT></clueSource> on the IL-2 gene <clueType>expression</clueType> showed that overexpression of calcineurin (CN), a Ca2+/calmodulin-dependent protein phosphatase, can stimulate transcription from the IL-2 promoter through the NF-AT-binding site.</clue>
<comment>NER T22 MOD</comment></event>
<event KT="Other" id="E21">
<type class="Gene_expression"/>
<theme idref="T24"/>
<clue>Earlier studies on the IL-2 gene expression showed that <clueType>overexpression</clueType> <linkTheme>of</linkTheme> calcineurin (CN), a Ca2+/calmodulin-dependent protein phosphatase, can stimulate transcription from the IL-2 promoter through the NF-AT-binding site.</clue>
</event>
<event KT="Other" id="E22">
<type class="Positive_regulation"/>
<theme idref="E21"/>
<clue>Earlier studies on the IL-2 gene expression showed that <clueType>overexpression</clueType> of calcineurin (CN), a Ca2+/calmodulin-dependent protein phosphatase, can stimulate transcription from the IL-2 promoter through the NF-AT-binding site.</clue>
</event>
<event CL="L2" KT="Analysis" Source="Other" id="E23">
<type class="Positive_regulation"/>
<theme idref="T29"/>
<cause idref="E22"/>
<clue><clueSource>Earlier studies</clueSource> on the IL-2 gene expression <clueKT>showed</clueKT> that overexpression of calcineurin (CN), a Ca2+/calmodulin-dependent protein phosphatase, <clueCL>can</clueCL> <clueType>stimulate</clueType> transcription from the IL-2 promoter <linkTheme>through</linkTheme> the NF-AT-binding site.</clue>
</event>
<event KT="Other" id="E24">
<type class="Transcription"/>
<theme idref="T27"/>
<clue>Earlier studies on the IL-2 gene expression showed that overexpression of calcineurin (CN), a Ca2+/calmodulin-dependent protein phosphatase, can stimulate <clueType>transcription</clueType> <linkTheme>from</linkTheme> the IL-2 promoter through the NF-AT-binding site.</clue>
</event>
<event KT="Other" id="E25">
<type class="Positive_regulation"/>
<theme idref="E24"/>
<cause idref="E23"/>
<clue>Earlier studies on the IL-2 gene expression showed that overexpression of calcineurin (CN), a Ca2+/calmodulin-dependent protein phosphatase, can <clueType>stimulate</clueType> transcription from the IL-2 promoter <linkCause>through</linkCause> the NF-AT-binding site.</clue>
</event>
<sentence id="S5">In this study, we obtained evidence that transfection of the <term id="T30" lex="cDNA" sem="DNA_family_or_group">cDNAs</term> <term id="A7" sem="DNA_molecule">for</term> <cons id="T31" lex="(AND CN_A_(catalytic)_subunit CN_B_(regulatory)_subunit)" sem="(AND Protein_molecule Protein_molecule)"><frag id="F1"><term id="A4" sem="Protein_molecule">CN A</term> (catalytic)</frag> and <frag id="F2"><term id="A5" sem="Protein_molecule">CN B</term> (regulatory)</frag> <frag id="F3"><term id="A6" sem="Protein_molecule">subunits</term></frag></cons> also augments transcription from the <term id="T32" lex="GM-CSF_promoter" sem="DNA_domain_or_region"><term id="T33" lex="GM-CSF" sem="Protein_molecule">GM-CSF</term> promoter</term> and recovers the transcription inhibited by <term id="T34" lex="CsA" sem="Organic_compound_other">CsA</term>.</sentence>
<event KT="Method" id="E126">
<type class="Gene_expression"/>
<theme idref="A5" idref1="A6"/>
<clue>In this study, we obtained evidence that <clueType>transfection</clueType> <linkTheme>of</linkTheme> the cDNAs for CN A (catalytic) and CN B (regulatory) subunits also augments transcription from the GM-CSF promoter and recovers the transcription inhibited by CsA.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Method" id="E127">
<type class="Positive_regulation"/>
<theme idref="E126"/>
<clue>In this study, we obtained evidence that <clueType>transfection</clueType> of the cDNAs for CN A (catalytic) and CN B (regulatory) subunits also augments transcription from the GM-CSF promoter and recovers the transcription inhibited by CsA.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Method" id="E128">
<type class="Gene_expression"/>
<theme idref="A4" idref1="A6"/>
<clue>In this study, we obtained evidence that <clueType>transfection</clueType> <linkTheme>of</linkTheme> the cDNAs for CN A (catalytic) and CN B (regulatory) subunits also augments transcription from the GM-CSF promoter and recovers the transcription inhibited by CsA.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Method" id="E129">
<type class="Positive_regulation"/>
<theme idref="E128"/>
<clue>In this study, we obtained evidence that <clueType>transfection</clueType> of the cDNAs for CN A (catalytic) and CN B (regulatory) subunits also augments transcription from the GM-CSF promoter and recovers the transcription inhibited by CsA.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Other" id="E28">
<type class="Transcription"/>
<theme idref="T32"/>
<clue>In this study, we obtained evidence that transfection of the cDNAs for CN A (catalytic) and CN B (regulatory) subunits also augments <clueType>transcription</clueType> <linkTheme>from</linkTheme> the GM-CSF promoter and recovers the transcription inhibited by CsA.</clue>
</event>
<event CL="L2" KT="Analysis" id="E29">
<type class="Positive_regulation"/>
<theme idref="E28"/>
<cause idref="E127"/>
<clue>In this study, we obtained <clueKT><clueCL>evidence</clueCL></clueKT> that transfection of the cDNAs for CN A (catalytic) and CN B (regulatory) subunits also <clueType>augments</clueType> transcription from the GM-CSF promoter and recovers the transcription inhibited by CsA.</clue>
</event>
<event CL="L2" KT="Analysis" id="E30">
<type class="Positive_regulation"/>
<theme idref="E28"/>
<cause idref="E129"/>
<clue>In this study, we obtained <clueKT><clueCL>evidence</clueCL></clueKT> that transfection of the cDNAs for CN A (catalytic) and CN B (regulatory) subunits also <clueType>augments</clueType> transcription from the GM-CSF promoter and recovers the transcription inhibited by CsA.</clue>
</event>
<event KT="Other" id="E31">
<type class="Negative_regulation"/>
<theme idref="E28"/>
<cause idref="T34"/>
<clue>In this study, we obtained evidence that transfection of the cDNAs for CN A (catalytic) and CN B (regulatory) subunits also augments transcription from the GM-CSF promoter and recovers <corefTheme>the transcription</corefTheme> <clueType>inhibited</clueType> <linkCause>by</linkCause> CsA.</clue>
</event>
<event CL="L2" KT="Analysis" id="E32">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="E127"/>
<clue>In this study, we obtained <clueKT><clueCL>evidence</clueCL></clueKT> that transfection of the cDNAs for CN A (catalytic) and CN B (regulatory) subunits also augments transcription from the GM-CSF promoter and <clueType>recovers</clueType> the transcription inhibited by CsA.</clue>
</event>
<event CL="L2" KT="Analysis" id="E33">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="E129"/>
<clue>In this study, we obtained <clueKT><clueCL>evidence</clueCL></clueKT> that transfection of the cDNAs for CN A (catalytic) and CN B (regulatory) subunits also augments transcription from the GM-CSF promoter and <clueType>recovers</clueType> the transcription inhibited by CsA.</clue>
</event>
<sentence id="S6"><term id="A101" sem="Protein_molecule">The constitutively active type of the <term id="T35" lex="CN_A_subunit" sem="Protein_molecule">CN A subunit</term></term>, which lacks the <term id="T36" lex="auto-inhibitory_domain" sem="Protein_domain_or_region">auto-inhibitory</term> and <term id="T37" lex="calmodulin-binding_domain" sem="Protein_domain_or_region">calmodulin-binding domains</term>, acts in synergy with <term id="T38" lex="PMA" sem="Organic_compound_other">PMA</term> to activate transcription from the <term id="T39" lex="GM-CSF_promoter" sem="DNA_domain_or_region">GM-CSF promoter</term>.</sentence>
<event id="E34">
<type class="Transcription"/>
<theme idref="T39"/>
<clue>The constitutively active type of the CN A subunit, which lacks the auto-inhibitory and calmodulin-binding domains, acts in synergy with PMA to activate <clueType>transcription</clueType> <linkTheme>from</linkTheme> the GM-CSF promoter.</clue>
<comment>TPS A101</comment></event>
<event id="E35">
<type class="Correlation"/>
<theme idref="A101"/>
<theme idref="T38"/>
<clue>The constitutively active type of the CN A subunit, which lacks the auto-inhibitory and calmodulin-binding domains, <clueType>acts in synergy</clueType> <linkTheme>with</linkTheme> PMA to activate transcription from the GM-CSF promoter.</clue>
</event>
<event id="E135">
<type class="Positive_regulation"/>
<theme idref="E34"/>
<cause idref="E35"/>
<clue>The constitutively active type of the CN A subunit, which lacks the auto-inhibitory and calmodulin-binding domains, acts in synergy with PMA <clueType>to activate</clueType> transcription from the GM-CSF promoter.</clue>
</event>
<sentence id="S7">We also found that the active <term id="T40" lex="CN" sem="Protein_molecule">CN</term> partially replaces <term id="T41" lex="calcium_ionophore" sem="Organic_compound_other"><term id="T42" lex="calcium" sem="Element">calcium</term> ionophore</term> in synergy with <term id="T43" lex="PMA" sem="Organic_compound_other">PMA</term> to induce expression of endogenous <term id="T44" lex="GM-CSF" sem="Protein_molecule">GM-CSF</term> and <term id="T45" lex="IL-2" sem="Protein_molecule">IL-2</term>.</sentence>
<event id="E36">
<type class="Gene_expression"/>
<theme idref="T44"/>
<clue>We also found that the active CN partially replaces calcium ionophore in synergy with PMA to induce <clueType>expression</clueType> <linkTheme>of</linkTheme> endogenous GM-CSF and IL-2.</clue>
</event>
<event id="E37">
<type class="Gene_expression"/>
<theme idref="T45"/>
<clue>We also found that the active CN partially replaces calcium ionophore in synergy with PMA to induce <clueType>expression</clueType> <linkTheme>of</linkTheme> endogenous GM-CSF and IL-2.</clue>
</event>
<event id="E138">
<type class="Correlation"/>
<theme idref="A101"/>
<theme idref="T43"/>
<clue>We also <clueKT>found</clueKT> that <corefCause>the active CN</corefCause> partially <clueType>replaces</clueType> calcium ionophore <clueType>in synergy</clueType> <linkTheme>with</linkTheme> PMA to induce expression of endogenous GM-CSF and IL-2.</clue>
</event>
<event id="E38">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<cause idref="E138"/>
<clue>We also found that the active CN partially replaces calcium ionophore in synergy with PMA <clueType>to induce</clueType> expression of endogenous GM-CSF and IL-2.</clue>
</event>
<event id="E39">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="E138"/>
<clue>We also found that the active CN partially replaces calcium ionophore in synergy with PMA <clueType>to induce</clueType> expression of endogenous GM-CSF and IL-2.</clue>
</event>
<sentence id="S8">By multimerizing the <term id="T46" lex="regulatory_element" sem="DNA_family_or_group">regulatory elements</term> of the <term id="T47" lex="GM-CSF_promoter" sem="DNA_domain_or_region"><term id="T48" lex="GM-CSF" sem="Protein_molecule">GM-CSF</term> promoter</term>, we found that one of the <term id="T49" lex="target_site" sem="DNA_domain_or_region">target sites</term> for the <term id="T50" lex="CN" sem="Protein_molecule">CN</term> action is the <term id="T51" lex="conserved_lymphokine_element_0" sem="DNA_domain_or_region">conserved lymphokine element 0</term> (<term id="T52" lex="CLE0" sem="DNA_domain_or_region">CLE0</term>), located at positions between <term id="T53" lex="-54_and_-40" sem="DNA_substructure">-54 and -40</term>.</sentence>
<event id="E41">
<type class="Regulation"/>
<theme idref="T52"/>
<cause idref="T50"/>
<clue><clueExperiment>By multimerizing the regulatory elements of the GM-CSF promoter</clueExperiment>, we <clueKT>found</clueKT> that one of the <clueType>target sites</clueType> <linkCause>for</linkCause> the CN action is the conserved lymphokine element 0 (CLE0), located at positions between -54 and -40.</clue>
</event>
<sentence id="S9"><term id="T54" lex="mobility_shift_assay" sem="Other">Mobility shift assays</term> showed that the <term id="T55" lex="CLE0" sem="DNA_domain_or_region">CLE0</term> sequence has an <term id="T56" lex="AP1-binding_site" sem="DNA_domain_or_region"><term id="A201" sem="Protein_complex">AP1</term>-binding site</term> and is associated with an <term id="T57" lex="NF-AT-like_factor" sem="Protein_family_or_group">NF-AT-like factor</term>, termed <term id="T58" lex="NF-CLE0_gamma" sem="Protein_molecule">NF-<term id="T59" lex="CLE0" sem="DNA_domain_or_region">CLE0</term> gamma</term>.</sentence>
<event KT="Analysis" id="E42">
<type class="Binding"/>
<theme idref="T55"/>
<theme idref="T58"/>
<clue><clueExperiment>Mobility shift assays</clueExperiment> <clueKT>showed</clueKT> that the CLE0 sequence has an AP1-binding site and is <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> <corefTheme>an NF-AT-like factor</corefTheme>, termed NF-CLE0 gamma.</clue>
</event>
<event KT="Analysis" id="E142">
<type class="Binding"/>
<theme idref="T55"/>
<theme idref="A201"/>
<clue><clueExperiment>Mobility shift assays</clueExperiment> <clueKT>showed</clueKT> that the CLE0 sequence <clueType>has</clueType> an AP1-<clueType>binding site</clueType> and is associated with an NF-AT-like factor, termed NF-CLE0 gamma.</clue>
</event>
<sentence id="S10"><term id="A102" sem="Protein_molecule">NF-<term id="T60" lex="CLE0" sem="DNA_domain_or_region">CLE0</term> gamma</term> binding is induced by <term id="T61" lex="PMA" sem="Organic_compound_other">PMA</term>/<term id="A103" sem="Organic_compound_other">A23187</term> and is inhibited by treatment with <term id="T62" lex="CsA" sem="Organic_compound_other">CsA</term>.</sentence>
<event id="E43">
<type class="Binding"/>
<theme idref="A102"/>
<theme idref="T55"/>
<clue>NF-CLE0 gamma <clueType>binding</clueType> is induced by PMA/A23187 and is inhibited by treatment with CsA.</clue>
<comment>NO COREFTHEME FOR T55</comment></event>
<event id="E44">
<type class="Positive_regulation"/>
<theme idref="E43"/>
<cause idref="A103"/>
<cause idref="T61"/>
<clue>NF-CLE0 gamma binding is <clueType>induced</clueType> <linkCause>by</linkCause> PMA/A23187 and is inhibited by treatment with CsA.</clue>
</event>
<event id="E45">
<type class="Negative_regulation"/>
<theme idref="E43"/>
<cause idref="T62"/>
<clue>NF-CLE0 gamma binding is induced by PMA/A23187 and is <clueType>inhibited</clueType> <linkCause>by treatment with</linkCause> CsA.</clue>
</event>
<sentence id="S11">These results suggest that <term id="T63" lex="CN" sem="Protein_molecule">CN</term> is involved in the coordinated induction of the <cons id="T64" lex="(AND GM-CSF_gene IL-2_gene)" sem="(AND DNA_domain_or_region DNA_domain_or_region)"><frag id="F4">GM-CSF</frag> and <frag id="F5">IL-2</frag> <frag id="F6">genes</frag></cons> and that the <term id="T65" lex="CLE0_sequence" sem="DNA_domain_or_region"><term id="T66" lex="CLE0" sem="DNA_domain_or_region">CLE0</term> sequence</term> of the <term id="T67" lex="GM-CSF_gene" sem="DNA_domain_or_region"><term id="T68" lex="GM-CSF" sem="Protein_molecule">GM-CSF</term> gene</term> is a functional analogue of the <term id="T69" lex="NF-AT-binding_site" sem="DNA_domain_or_region">NF-AT-binding site</term> in the <term id="T70" lex="IL-2_promoter" sem="DNA_domain_or_region"><term id="T71" lex="IL-2" sem="Protein_molecule">IL-2</term> promoter</term>, which mediates signals downstream of <term id="T72" lex="T_cell_activation" sem="Other"><term id="A107" sem="Cell_natural">T cell</term> activation</term>.</sentence>
<event KT="Other" id="E46">
<type class="Positive_regulation"/>
<theme idref="F4" idref1="F6"/>
<clue>These results suggest that CN is involved in the coordinated <clueType>induction</clueType> <linkTheme>of</linkTheme> the GM-CSF and IL-2 genes and that the CLE0 sequence of the GM-CSF gene is a functional analogue of the NF-AT-binding site in the IL-2 promoter, which mediates signals downstream of T cell activation.</clue>
</event>
<event KT="Other" id="E47">
<type class="Positive_regulation"/>
<theme idref="F5" idref1="F6"/>
<clue>These results suggest that CN is involved in the coordinated <clueType>induction</clueType> <linkTheme>of</linkTheme> the GM-CSF and IL-2 genes and that the CLE0 sequence of the GM-CSF gene is a functional analogue of the NF-AT-binding site in the IL-2 promoter, which mediates signals downstream of T cell activation.</clue>
</event>
<event KT="Other" id="E48">
<type class="Correlation"/>
<theme idref="E46"/>
<theme idref="E47"/>
<clue>These results suggest that CN is involved in the <clueType>coordinated</clueType> induction of the GM-CSF and IL-2 genes and that the CLE0 sequence of the GM-CSF gene is a functional analogue of the NF-AT-binding site in the IL-2 promoter, which mediates signals downstream of T cell activation.</clue>
</event>
<event CL="L2" KT="Analysis" id="E49" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E48"/>
<cause idref="T63"/>
<clue>These results <clueKT><clueCL>suggest</clueCL></clueKT> that CN is <clueType>involved</clueType> <linkTheme>in</linkTheme> the coordinated induction of the GM-CSF and IL-2 genes and that the CLE0 sequence of the GM-CSF gene is a functional analogue of the NF-AT-binding site in the IL-2 promoter, which mediates signals downstream of T cell activation.</clue>
</event>
<event KT="Other" id="E50">
<type class="Physiological_process"/>
<theme idref="A107"/>
<clue>These results suggest that CN is involved in the coordinated induction of the GM-CSF and IL-2 genes and that the CLE0 sequence of the GM-CSF gene is a functional analogue of the NF-AT-binding site in the IL-2 promoter, which mediates signals downstream of T cell <clueType>activation</clueType>.</clue>
</event>
<event KT="Other" id="E51">
<type class="Cell_communication"/>
<theme idref="E49"/>
<clue>These results suggest that CN is involved in the coordinated induction of the GM-CSF and IL-2 genes and that the CLE0 sequence of the GM-CSF gene is a functional analogue of the NF-AT-binding site in the IL-2 promoter, which mediates <clueType>signals</clueType> <linkTheme>downstream of</linkTheme> T cell activation.</clue>
</event>
<event CL="L2" KT="Analysis" id="E52">
<type class="Positive_regulation"/>
<theme idref="E51"/>
<cause idref="T66"/>
<clue>These results <clueKT><clueCL>suggest</clueCL></clueKT> that CN is involved in the coordinated induction of the GM-CSF and IL-2 genes and that the CLE0 sequence of the GM-CSF gene is a functional analogue of the NF-AT-binding site in the IL-2 promoter, which <clueType>mediates</clueType> signals downstream of T cell activation.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
